Profile
BGMS ONC WBA DFTX HROWL HROWM
Company Name Bio Green Med Solution, Inc. BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $2.01M $37.82B $10.37B $1.64B $1.37B $1.34B
Employees 0.00K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO Sing Ee Wong John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
BGMS ONC WBA DFTX HROWL HROWM
Quant Rating Score 2 2 2 1 1 1
Quant Rating Sell Sell Sell Strong Sell Strong Sell Strong Sell
Trading
BGMS ONC WBA DFTX HROWL HROWM
Last Close $1.21 $376.63 $11.98 - $25.61 $26.03
High 52 $6.02 $377.81 $12.93 - $25.72 $26.95
Low 52 $1.23 $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -79.9 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low -1.63 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
BGMS ONC WBA DFTX HROWL HROWM
1 Month Return -70.05 % 19.03 % 0 % - 0 % 0 %
3 Month Return 0 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return 0 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return 0 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return 0 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return 0 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
BGMS ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -148.61 % 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) -0.75 % - -10.29 % - - -
Growth
BGMS ONC WBA DFTX HROWL HROWM
Asset Growth -53.5 % 1.99 % -16.14 % 24.77 % 24.77 %
Gross Profit Growth -89.76 % 54.71 % -2.02 % 66.06 % 66.06 %
Revenue Growth -89.76 % 54.96 % 6.17 % 53.32 % 53.32 %
Revenue 3 Year - 185.46 % 11.65 % 106.71 % 106.71 %
Revenue 5 Year - 407.52 % 31.29 % 177.12 % 177.12 %
Revenue 10 Year -100 % 14520 % 113.45 % 2980.55 % 2980.55 %
EBIT Growth 52.84 % 52.95 % -183.88 % 1018.99 % 1018.99 %
Net Income Growth 50.29 % 26.87 % -180.39 % 28.39 % 28.39 %
Net Income 3 Yeari Growth Per Share 93.25 % 61.02 % -440.4 % 27.14 % 27.14 %
Net Income 5 Yeari Growth Per Share 98.55 % 61.23 % -331.55 % -7491.01 % -7491.01 %
Net Income 10 Yeari Growth Per Share 99.93 % -1664.38 % -593.61 % 55.74 % 55.74 %
Operating Income Growth 52.84 % 52.95 % -104.53 % 1946.87 % 1946.87 %
Operating Cash Flow Growth (CFG) 50.41 % 87.85 % -54.92 % -678.18 % -678.18 %
Operating 3 Year CFG 95.21 % 90.46 % -81.64 % -427.89 % -427.89 %
Operating 5 Year CFG 99.14 % 89.31 % -80.57 % -1760.03 % -1760.03 %
Operating 10 Year CFG 99.95 % -709.03 % -71.12 % 19.39 % 19.39 %
EPS Growth 92.19 % 27.57 % -180.39 % 34.67 % 34.67 %
EPS Diluted Growth 92.19 % 27.57 % -180.39 % 34.67 % 34.67 %
Book Value Per Share -156.9 % -6.6 % -57.24 % -9.43 % -9.43 %
Share Holder 3 Year Equity Growth Per Share -100.64 % -52.12 % -56.07 % 363.19 % 363.19 %
Share Holder 5 Year Equity Growth Per Share -100.19 % 97.53 % -53.83 % 78.54 % 78.54 %
Share Holder 10 Year Equity Growth Per Share -100.01 % 6367.84 % -43.9 % 118.93 % 118.93 %
Dividend Per Share Growth -100 % - -24.04 % - -
Dividend 3 Year Growth Per Share -100 % - -21.92 % -100 % -100 %
Dividend 5 Year Growth Per Share -100 % - -18.12 % - -
Dividend 10 Year Growth Per Share -100 % - 16.05 % - -
Debt Growth -100 % 16.09 % 0.7 % 20.12 % 20.12 %
Free Cash Flow Growth 50.43 % 61.81 % -357.45 % 59.06 % 59.06 %
Updated On 31 Dec 2024 31 Dec 2024 31 Aug 2024 31 Dec 2024 31 Dec 2024
Profitability
BGMS ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM 18.52 % 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -66.67 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM -187.31 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM -128.19 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM 128.19 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM 46.26 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM -11324.69 % 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM -121860 % 77 % 5.43 % - 7.02 % 7.02 %
Receivables Turnover TTM 0.11 5.83 23.42 - 3.21 3.21
Payables Turnover TTM 0.14 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM 0.05 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM 56.25 % 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM 0.99 % 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM -8.07 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM -8.07 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 508.4 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM -7522.22 % 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM -121860 % 77 % 5.43 % - 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM -0.33 88.39 17.88 -14.42 -85.37 -85.6
Price To Operating Cash Flows Ratio TTM -0.13 5.51 6.57 -12.74 99.18 99.45
Price Cash Flow Ratio TTM -0.13 5.51 6.57 -12.74 99.18 99.45
Income Statement (TTM)
BGMS ONC WBA DFTX HROWL HROWM
Revenue $0B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 100% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $-0.01B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0.01B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted -501.6 -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
BGMS ONC WBA DFTX HROWL HROWM
Long Term Debt $0B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0.01B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $-0B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
BGMS ONC WBA DFTX HROWL HROWM
Net Income $-0.01B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $0B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $0B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.42
ATAI Atai Life Sciences N.V. 3.77
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMSP Bio Green Med Solution, Inc. 3.73
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 12.23
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 16.9
HITI High Tide Inc. 2.35
HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares 0.827
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 8.22
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 3.14
LFMDP LifeMD, Inc. 22.7
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
MSLE Satellos Bioscience Inc. Common Stock 11.25
Unlock